Bioscience

CereHealth granted patent for medical imaging quantification

CereHealth granted patent for medical imaging quantification

DENVER -- CereHealth Corporation announced it has been granted a third patent on its novel systems and methodologies used in its FDA-cleared CereMetrix medical imaging and data analytics software. ... Read More

Friday April 23, 2021 0 comments Tags: Denver, CereHealth, John Kelley

Research shows Ampion mimics anti-inflammatory effects of steroids but without adverse effects

Research shows Ampion mimics anti-inflammatory effects of steroids but without adverse effects

ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced findings of pre-clinical research demonstrating Ampio's lead drug candidate, Ampion, provides some of the same anti-inflammatory... Read More

Tuesday April 20, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Dr. David Bar-Or, Michael Macaluso

VieCure announces $25M Series A investment led by Northpond Ventures to improve oncology care, scale A.I. and patient-focused technologies

VieCure announces $25M Series A investment led by Northpond Ventures to improve oncology care, scale A.I. and patient-focused technologies

DENVER -- VieCure , Inc . today announced the closing of a $25 million Series A growth equity investment, led by Northpond Ventures . An undisclosed investor is also contributing to the... Read More

Tuesday April 20, 2021 0 comments Tags: Denver, Viecure, Gerry Hogue

TriSalus Life Sciences and MD Anderson Cancer Center announce research collaboration to evaluate treatment of solid tumors

TriSalus Life Sciences and MD Anderson Cancer Center announce research collaboration to evaluate treatment of solid tumors

DENVER -- The University of Texas MD Anderson Cancer Center and Denver-based TriSalus Life Sciences announced a strategic research collaboration to evaluate the treatment of tumors of the... Read More

Thursday April 15, 2021 0 comments Tags: Denver, TriSalus Life Sciences, MD Anderson Cancer Center, Steven Katz

Flagship Biosciences and Leap Therapeutics announce partnership and approach using RNAscope and Image Analysis for patient enrollment

Flagship Biosciences and Leap Therapeutics announce partnership and approach using RNAscope and Image Analysis for patient enrollment

WESTMINSTER and CAMBRIDGE, Mass. -- Flagship Biosciences , a leader in data-centric pathology and tissue analysis, and Massachusetts-based Leap Therapeutics (Nasdaq: LPTX), a biotechnology... Read More

Wednesday April 14, 2021 0 comments Tags: Westminster, Flagship Biosciences, Leap Therapeutics, Trevor Johnson

Ampio study: Ampion inhibits key inflammatory pathway in COVID-19 and lupus nephritis

Ampio study: Ampion inhibits key inflammatory pathway in COVID-19 and lupus nephritis

ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced results of a pre-clinical study demonstrating Ampion inhibits an important pro-inflammatory pathway in the types of immune cells... Read More

Friday April 9, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, lupus nephritis, Dr. David Bar-Or

CU: Carbon dioxide levels reflect COVID-19 risk

CU: Carbon dioxide levels reflect COVID-19 risk

BOULDER -- Tracking carbon dioxide levels indoors is an inexpensive and powerful way to monitor the risk of people getting COVID-19, according to new research from the Cooperative Institute for... Read More

Friday April 9, 2021 0 comments Tags: Boulder, CU Boulder, COVID-19, Zhe Peng

Applied Spectral Imaging and KromaTiD announce strategic partnership

Applied Spectral Imaging and KromaTiD announce strategic partnership

LONGMONT/CARLSBAD, Calif. -- KromaTiD and California-based Applied Spectral Imaging (ASI) announced they have entered into a strategic commercial partnership, granting ASI worldwide rights to... Read More

Friday April 9, 2021 0 comments Tags: Longmont, KromaTid, David Sebesta, Applied Spectral Imaging